OP Asset Management Ltd Buys New Stake in The Cooper Companies, Inc. $COO

OP Asset Management Ltd bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the 1st quarter, according to its most recent 13F filing with the SEC. The fund bought 20,372 shares of the medical device company’s stock, valued at approximately $1,457,000.

Other hedge funds also recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Cooper Companies by 48.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock worth $1,890,000 after acquiring an additional 7,363 shares during the last quarter. First Trust Advisors LP raised its position in shares of Cooper Companies by 115.8% in the 2nd quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock valued at $9,702,000 after purchasing an additional 73,165 shares during the last quarter. Cresset Asset Management LLC purchased a new position in shares of Cooper Companies in the 2nd quarter valued at approximately $291,000. Cerity Partners LLC boosted its stake in Cooper Companies by 4.4% in the 2nd quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock worth $1,272,000 after purchasing an additional 757 shares in the last quarter. Finally, Daiwa Securities Group Inc. boosted its stake in Cooper Companies by 2.8% in the 2nd quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock worth $2,551,000 after purchasing an additional 973 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on COO shares. Weiss Ratings lowered shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. Piper Sandler set a $86.00 target price on Cooper Companies and gave the stock an “overweight” rating in a research note on Monday, June 1st. Barclays lifted their price target on Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, March 6th. Citigroup reissued a “neutral” rating and issued a $69.00 price objective (down from $80.00) on shares of Cooper Companies in a report on Thursday, May 28th. Finally, JPMorgan Chase & Co. reduced their price objective on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research note on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have given a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $81.31.

Cooper Companies Trading Up 0.5%

NASDAQ COO opened at $71.39 on Tuesday. The company has a market capitalization of $13.92 billion, a PE ratio of 60.50, a P/E/G ratio of 1.86 and a beta of 0.88. The company has a fifty day moving average of $64.14 and a 200 day moving average of $73.56. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period last year, the firm earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Research analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.